The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about many questions as hospitals and blood centers prepare to order the testing. We've put together a FAQ document to clarify what we know today. We will update the document as we get more information on existing questions and as new questions get asked, and will update the blog with the revised FAQ document.
Thanks for your support as we work to rapidly get this testing available to you. You can find the FAQ document here: CTS COVID-19 Questions and Answers
The new online Learning Center with new content can still be found under the “Training” folder on ...
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
We are very excited to launch our new website! Please take a few moments to click around and explore...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...